Christopher A. Alabi
Sequence-defined oligomers; drug delivery; antibacterial agents; intracellular probes; programmable materials, change antibacterial agents to targeted antibiotics
Current Research Interest
Synthetic methods for the assembly of sequence-defined oligomers; development of macromolecular antibacterial and cell penetrating agents; sequence-structure-function relationships; design and development of intracellular probes for measuring organelle specific enzyme kinetics; assembly of new sequence-defined macromolecules that can be used to create stimuli-responsive materials
PSME Young Investigator Award
Cornell University Tau Beta Pi Professor of the Year Award
Cornell University College of Engineering Research Excellence Award
National Science Foundation CAREER Award
American Chemical Society Petroleum Research Fund Award
Pharmaceutical Research and Manufacturers of America Foundation Research Starter
Brown, Joseph S., Zeineb J. Mohamed. Christine M. Artim, Dana N. Thornlow, Joseph F. Hassler, Vincent P. Rigoglioso, Susan Daniel, and Christopher A. Alabi. “Antibacterial Isoamphipathic Oligomers Highlight the Importance of Multimeric Lipid Aggregation for Antibacterial Potency.” Communications Biology 1 (2018): 220.
Porel, Mintu, Dana N. Thornlow, Ngoc N. Phan, and Christopher A. Alabi. “Sequence-Defined Bioactive Macrocycles via an Acid-Catalyzed Cascade Reaction.” Nature Chemistry 8, no. 6 (2016): 590-596.